AI assistant
GlaxoSmithKline PLC — Director's Dealing 2016
Jul 20, 2016
5262_dirs_2016-07-20_de040db9-aeaa-458c-a46e-3d3ccbbaee83.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 6653E
GlaxoSmithKline PLC
19 July 2016
GlaxoSmithKline plc (the 'Company')
Transaction notification
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Mr S Dingemans
b)
Position/status
CFO
c)
Initial notification/
amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
b)
Nature of the transaction
Increase in notional interest in Ordinary Shares following the re-investment of dividends paid to shareholders on 14 July 2016 on Ordinary Shares held in the Company's 2009 Performance Share Plan.
c)
Price(s) and
volume(s)
| Price(s) | Volume(s) |
| £16.285 | 2,339.893 |
| £16.285 | 2,399.173 |
| £16.285 | 2,598.401 |
d)
Aggregated information
Aggregated volume Price
7,337.467
£16.285
e)
Date of the transaction
2016-07-14
f)
Place of the transaction
n/a
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHVKLFFQDFXBBL
//<![CDATA[$.ajaxSetup({headers: {'__RequestVerificationToken':'pGB97F7N-M-w7dJD_c83nWDtALGsHIPlT51nazVzSQt5QD_Y2LSc5F4HaWYryMfIiBTwc8q1v77WmJbdiL1y022ab9Owdkt1MRVjYDJY_1s1:OtbdH6mmz8QFFfeMV0anGolZdIxhoFMPjX9q724v4ie6xOsEI1gJgcd3fYjo2ow1M0BB2FtjflHh0rQrfQHF1xTFclBk0pOfc4K8i1Sqo7Q1'}});//]]>